Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Pancreatic Neoplasms 3 Pancreatic Cyst 2 Wilms Tumor 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Diseases 1 Prostatic Neoplasms 1 Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Intestinal Neuroendocrine Tumor 1 Hyperthyroidism 1 Hip Fractures 1 Hematologic Neoplasms 1 Goiter 1 Glioma 1 Glioblastoma 1 Frailty 1 Fractures, Spontaneous 1 Financial Stress 1

Interventions

Temozolomide 42 Magnetic Resonance Spectroscopy 41 Radiotherapy 23 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 9 trametinib 8 Nivolumab 7 Blood Specimen Collection 7 Bevacizumab 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 Lomustine 5 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4 vorasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Data Collection × 1 year × Clear all

NCT07499141 2026-03-30

UFGAG

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡